Zephyrus Biosciences Company
Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single-cell analysis market, our first product, the scWestern system, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development.
Investors
Founded Date:
2013-01-01
Last Funding Type:
Seed
Headquarters:
Berkeley, California, United States
Investors Number:
10
Technology:
Regenerative Medicine
Employee Number:
1-10
Industry:
Biotechnology, Hardware, Health Care
Number Of Exists:
Seed
Funding Status:
M&A
Investor Type:
For Profit
Total Funding:
$1.9M